Navigation Links
Dragon announces new product launch; increase in annual production output capacity
Date:3/5/2008

VANCOUVER, March 5 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company today announced the Company has increased its annual production capacity for its core products 7ACA and Clavulanic Acid by 30% and 56% respectively in order to meet increasing demand from its customers. Meanwhile, two new products Ceftazidime and Cefalexin, which were commercially launched in January 2008, have been added to Dragon's product portfolio.

In October 2007, Dragon successfully adopted an enzymatic process to its production of 7ACA. The enzymatic process is an environmentally friendly technology and the Company is now in the process of converting its entire production to incorporate this innovative technology. Once fully implemented, Dragon expects to further increase its manufacturing capacity from the current 600 tons to 780 tons yearly. The process will lower production costs by approximately 10% and additionally will reduce the amount of capital investment pertaining to environmental issues.

Annual production capacity of Clavulanic Acid has also been increased from 50 tons to 78 tons as a result of the addition of a new 120 ton capacity fermentor. As the first and largest producer of Clavulanic Acid in China, Dragon's sales have increased dramatically, rising from 16 tons in 2005 to 39 tons in 2007.

With a core business strategy to become a leading vertically integrated antibiotic drugs manufacturer, the Company will continuously broaden its product portfolio. In January 2008, Dragon successfully launched two new products, Ceftazidime and Cefalexin, to the Chinese market. Given the high demand for these drugs in the Chinese market, these two products are expected to become Dragon's growth driver in the coming years.

Ceftazidime is a third-generation cephalosporin antibiotic, a downstream product for 7ACA, and has broad-spectrum activity aga
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dragon Announces R&D Achievement in Biotech Manufacturing Process
2. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
3. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
4. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
5. China Yingxia International Announces Q4 and FY 2007 Estimates
6. Bristol-Myers Squibb Announces Dividend
7. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
8. Maxygen Announces Management Changes
9. Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility
10. Exanet Announces ExaStore 2008 Clustered NAS System
11. Enerkem announces progress on construction of Canadas first cellulosic ethanol plant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... October 20, 2014 The report ... Dispensing Systems, Packaging and Labeling Systems, Table-top Counters) ... - Global Forecasts & Trends to 2019” analyzes ... opportunities in North America, Europe, Asia-Pacific, and the ... market tables and 30 figures spread through 300 ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014 ... that the Company has signed a Notice of ... Regenerative Medicine (CIRM), effective October 1, 2014.  The ... Development payments and the release of additional grant ... CIRM grant award for clinical development of Asterias, ...
(Date:10/20/2014)...  GenVec, Inc. (NASDAQ: GNVC ) today announced ... its board of directors effective on October 24, 2014.   Dr. ... as its chairman from June 2006 to November 2013.  During ... Governance and Audit Committees of the board.  ... dedicated service to GenVec, and its stockholders," said Wayne ...
(Date:10/20/2014)... Earle Martin , Chief Executive ... Ellen Teplitzky, an experienced attorney specializing in business ... has joined the firm as Director of Legal ... NDA Partners provides legal services, including research, ... top law firms and their clients in cases ...
Breaking Biology Technology:Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2
... , , , ... , , , RNA ... tool for target identification and target validation,in therapeutic research. , ... A growing number of different cell lines are used for,gene ...
... , , ... , , , Since the ... of foreign genes,appeared a few years ago, RNAi has become a ... short double-stranded RNAs that are,homologous to the suppressed gene. These small ...
... , , ... , , , , ... detection of beer-spoilage bacteria on the,LightCycler Instrument) in combination with the ... on the MagNA Pure LC Instrument) offers,breweries an innovative and automated ...
Cached Biology Technology:Housekeeping Genes: Universal Positive,Controls in siRNA Knockdown Experiments 2Housekeeping Genes: Universal Positive,Controls in siRNA Knockdown Experiments 3Quantification of siRNA Silencing Efficiency,Using the LightCycler System 2Quantification of siRNA Silencing Efficiency,Using the LightCycler System 3Quantification of siRNA Silencing Efficiency,Using the LightCycler System 4Quantification of siRNA Silencing Efficiency,Using the LightCycler System 5Screening of Beer-Spoilage Bacteria Using,the LightCycler PCR Workflow System 2Screening of Beer-Spoilage Bacteria Using,the LightCycler PCR Workflow System 3Screening of Beer-Spoilage Bacteria Using,the LightCycler PCR Workflow System 4Screening of Beer-Spoilage Bacteria Using,the LightCycler PCR Workflow System 5
(Date:10/22/2014)... 20, 2014 The Nano-Bio Manufacturing Consortium (NBMC), ... Research Laboratory (AFRL), has chosen a project proposed by ... University of Arizona College of Medicine – ... project,s goal is to assess different sweat collection methods ... of sweat under a variety of human-body conditions, the ...
(Date:10/18/2014)... and stress-related psychiatric disorders are associated with ... molecular mechanisms underlying this relation are unknown. ... development of targeted preventive strategies and new ... This work is presented at the European ... an international group of researchers from Germany ...
(Date:10/17/2014)... . Why do ... to reproduce? And why are there two sexes anyway? These ... of the research journal Molecular Human Reproduction published ... Bielefeld University Bielefeld has compiled this special issue on sperm ... to copulate with several males in quick succession – chimpanzees ...
Breaking Biology News(10 mins):Nano-Bio Manufacturing Consortium Selects Project Proposed by Arizona Center for Integrative Medicine to Optimize Human Performance Monitoring Techniques 2Nano-Bio Manufacturing Consortium Selects Project Proposed by Arizona Center for Integrative Medicine to Optimize Human Performance Monitoring Techniques 3Researchers find why depression and aging linked to increased disease risk 2Sperm wars 2
... "the trots," "Montezuma,s Revenge," "the runs" and worse. But no ... medicine that could go straight to the offending bacteria to ... true if work by Texas A&M University scientists stays on ... A "medicine that grows" is how the phage concept ...
... Unusual features of the human placenta may be ... of maternal deaths during childbirth, according to evolutionary research ... as the loss of more than a pint of ... accounts for nearly 35 percent, or 125,000, of the ...
... on the latest news in science and technology, consider a ... for Nov. 9, 2011. The event, sponsored by the ... and brightest graduate students to display their research on clearly ... Institute of Technology, Rutgers University -- Newark and the University ...
Cached Biology News:Texas A&M center confronts antibiotic crisis with potential new bacterial treatment 2Texas A&M center confronts antibiotic crisis with potential new bacterial treatment 3Texas A&M center confronts antibiotic crisis with potential new bacterial treatment 4Evolution offers clues to leading cause of death during childbirth 2NJIT grad students display work at 7th annual Research Day on Nov. 9 2
... Label IT siRNA Tracker Intracellular Localization ... a straight forward approach to directly ... design, in an efficient yet non-destructive ... Subcellular localization and functional inhibition of ...
... LC/MS, using mass numbers as a trigger, ... for performing investigation and research of natural ... analytical and preparative operation. Switching between modes ... software. This support provides a quick solution ...
... Tracker Intracellular Localization Kit provides a straight ... siRNA, of your design, in an efficient ... experiments. Subcellular localization and functional inhibition of ... introduction of the labeled siRNA into mammalian ...
... Although the Beacon 2000 instrument can ... instrument, the Beacon 2000 Data Manager Software ... data imported directly from the instrument. These ... into commercially available spreadsheets, such as Microsoft ...
Biology Products: